Home
Lynx1 Capital Management reported a 9.8% stake in Cullinan Therapeutics CGEM · 5,766,090 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 9.8%
- Last report
- 14.5% · filed 25/10/10
- Shares held
- 5,766,090 sh
- Class
- Common Stock, par value $0.0001 per share
- Holder
- Lynx1 Capital Management
- Event date
- 25/09/30
- Filed
- 25/11/14
9.8% stake · −4.7pp from the last report
- Stake
- 9.8%
- Last report
- 14.5%
- Since last report
- −4.7pp
Cullinan Therapeutics trades, last 26 weeks
What else happened in Cullinan Therapeutics around then
Filed or reported within 30 days of the trade day · 25/08/31~25/10/30Lynx1 Capital Management's other 5% stake reports
- Lynx1 Capital Management
5% stakeTScan Therapeutics
5% stakeTScan Therapeutics
TCRX
13.1% stake
20,519,148 sh
13.1% stake
Filed 08/14
- Lynx1 Capital Management
5% stakeStoke Therapeutics
5% stakeStoke Therapeutics
STOK
6.5% stake
4,038,404 sh
6.5% stake
Filed 08/14
- Lynx1 Capital Management
5% stakeC4 Therapeutics
5% stakeC4 Therapeutics
CCCC
9.99% stake
15,423,691 sh
9.99% stake
Filed 08/14
- Lynx1 Capital Management
5% stakeiBio
5% stakeiBio
IBIO
5.4% stake
2,807,016 sh
5.4% stake
Filed 08/14
- Lynx1 Capital Management
5% stakeGH Research
5% stakeGH Research
GHRS
19.3% stake
13,263,288 sh
19.3% stake
Filed 08/14
